Sotalol Hydrochloride
Payments companies reported to CMS as associated with Sotalol Hydrochloride. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Sotalol Hydrochloride, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Sotalol Hydrochloride
These are the largest totals companies reported as associated with Sotalol Hydrochloride. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Alejandro Borquez | San Diego, CA | Pediatric Cardiology | $47,304.47 |
| Bradley Knight | Chicago, IL | Clinical Cardiac Electrophysiology | $24,002.30 |
| Jonathan Hsu | San Diego, CA | Clinical Cardiac Electrophysiology | $20,094.21 |
| Jeremy Moore | Los Angeles, CA | Pediatrics | $11,751.48 |
| Mitchell Cohen | Phoenix, AZ | Pediatric Cardiology | $11,702.88 |
| Rohit Loomba | Wauwatosa, WI | Pediatric Cardiology | $11,506.91 |
| Saul Flores | Houston, TX | Pediatric Critical Care Medicine | $11,434.36 |
| Jodi Myers | Columbia, SC | Family | $8,670.07 |
| Manish Jain | Concord, NC | Clinical Cardiac Electrophysiology | $7,940.25 |
| Ellis Rochelson | New York, NY | Pediatric Cardiology | $7,878.15 |
Prescribed Sotalol Hydrochloride?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.